INTERVENTIONAL, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF EPTINEZUMAB FOR THE PREVENTIVE TREATMENT OF MIGRAINE IN PATIENTS WITH A DUAL DIAGNOSIS OF MIGRAINE AND MEDICATION OVERUSE HEADACHE.
Datos básicos
Documentos
- No hay documentos
Participantes
Grupos
Financiadores - Promotores
H. LUNDBECK A/S
Cita
INTERVENTIONAL, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF EPTINEZUMAB FOR THE PREVENTIVE TREATMENT OF MIGRAINE IN PATIENTS WITH A DUAL DIAGNOSIS OF MIGRAINE AND MEDICATION OVERUSE HEADACHE. (19139A). H. LUNDBECK A/S. 2021-2022. IP:SAMUEL DIAZ INSA.
Portal de investigación